American Portfolios Advisors’s Fortress Biotech FBIO Stock Holding History

American Portfolios Advisors’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$387	Hold	30	–	–	﹤0.01%	3413
2022 Q2	$378	Hold	30	–	–	﹤0.01%	3417
2022 Q1	$612	Hold	30	–	–	﹤0.01%	3437
2021 Q4	$1.13K	Hold	30	–	–	﹤0.01%	3301
2021 Q3	$1.45K	Hold	30	–	–	﹤0.01%	3230
2021 Q2	$1.61K	Hold	30	–	–	﹤0.01%	3184
2021 Q1	$1.59K	Hold	30	–	–	﹤0.01%	3046
2020 Q4	$1.43K	Hold	30	–	–	﹤0.01%	2772
2020 Q3	$1.82K	Hold	30	–	–	﹤0.01%	2645
2020 Q2	$1.21K	Hold	30	–	–	﹤0.01%	2657
2020 Q1	$851	Hold	30	–	–	﹤0.01%	2585
2019 Q4	$1.16K	Hold	30	–	–	﹤0.01%	2673
2019 Q3	$635	Hold	30	–	–	﹤0.01%	2692
2019 Q2	$675	Hold	30	–	–	﹤0.01%	2625
2019 Q1	$801	Hold	30	–	–	﹤0.01%	2499
2018 Q4	$387	Hold	30	–	–	﹤0.01%	2328
2018 Q3	$720	Hold	30	–	–	﹤0.01%	2324
2018 Q2	$1.34K	Hold	30	–	–	﹤0.01%	2240
2018 Q1	$2.05K	Hold	30	–	–	﹤0.01%	2102
2017 Q4	$1.8K	Buy	+30	New	+$1.77K	﹤0.01%	2073

Other funds holding FBIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

American Portfolios Advisors's FBIO Position: Q3 2022 in Review

American Portfolios Advisors held its Fortress Biotech (FBIO) position steady in Q3 2022 at 30 shares worth $387. The position accounts for ﹤0.01% of the portfolio, ranked #3413.

American Portfolios Advisors first reported a position in FBIO in Q4 2017 and has held it in 20 quarters since. The position peaked at $2.05K in Q1 2018. 64 funds tracked by Wall St. Rank hold FBIO as of Q3 2022.

American Portfolios Advisors held 30 shares of Fortress Biotech worth $387 as of Q3 2022.
American Portfolios Advisors left its Fortress Biotech share count unchanged in Q3 2022.
Fortress Biotech made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3413 holding.
American Portfolios Advisors first reported a position in Fortress Biotech in Q4 2017 and has held it in 20 quarters since.
American Portfolios Advisors's Fortress Biotech position peaked at $2.05K in Q1 2018.
64 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.